कृपया अन्य खोज का प्रयास करें
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, and oral formulation of oxycodone for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol, indicated for the management of acute, severe, and persistent pain; Belbuca, a buccal film that contains buprenorphine; and Symproic, an oral formulation of naldemedine for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain. The company was formerly known as Collegium Pharmaceuticals, Inc. and changed its name to Collegium Pharmaceutical, Inc. in October 2003. Collegium Pharmaceutical, Inc. was incorporated in 2002 and is headquartered in Stoughton, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Gino Santini | 64 | 2012 | Lead Independent Director |
Joseph J. Ciaffoni | 50 | 2017 | President, CEO & Director |
John Gordon Freund | 67 | 2014 | Independent Director |
Gwen A. Melincoff | 70 | 2017 | Independent Director |
Rita J. Balice-Gordon | 61 | 2020 | Independent Director |
Neil F. McFarlane | 49 | 2022 | Independent Director |
Charles E. Argoff | - | - | Scientific Advisor |
Robert H. Dworkin | - | - | Scientific Advisor |
William T. Zempsky | - | - | Scientific Advisor |
Garen G. Bohlin | 76 | 2015 | Independent Director |
Bill McCarberg | - | - | Scientific Advisor |
Cynthia G. McCormick | - | - | Scientific Advisor |
Srinivas Nalamachu | - | - | Scientific Advisor |
Lynn R. Webster | - | - | Scientific Advisor |
Joseph V. Pergolizzi | 53 | - | Scientific Advisor |
Richard L. Rauck | - | - | Scientific Advisor |
John A. Fallon | 75 | 2016 | Independent Director |
Nathaniel P. Katz | - | - | Scientific Advisor |
Michael Thomas Heffernan | 60 | 2002 | Co-Founder & Independent Chairman |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है